Acord (association For Cooperative Operations Research And Development)
MCPHS / Novartis - Early Clinical Development - Translational Clinical Oncology
Acord (association For Cooperative Operations Research And Development), Cambridge, Massachusetts, us, 02140
Novartis BioMedical Research – Fellowships in Early Clinical DevelopmentThe Novartis BioMedical Research (BR), in conjunction with MCPHS, offers 5 unique post-PharmD Fellowship programs in Early Clinical Drug Development:Biomarker Development (BMD), Recruiting 1 positionEarly Clinical Development - Translational Medicine, Recruiting 3 positionsEarly Clinical Development – Translational Clinical Oncology (TCO), Recruiting 1 PositionDrug Development Quality Assurance (QA), Not recruitingRegulatory Affairs (RA), Recruiting 1 positionEach two-year program is designed to provide talented candidates with a high-quality, comprehensive and unique postdoctoral experience. Candidates will gain practical industry experience within the early clinical drug development setting at Novartis BR. Candidates will also have opportunities to advance their academic skill set as an adjunct faculty member at MCPHS.Fellowship Objectives
The Fellowship is comprised of the Novartis BR industry component and MCPHS academic component. Fellows will spend the majority of their time at Novartis BR obtaining real-world clinical trial experience with a smaller portion of time dedicated to MCPHS activities. Over the course of the two-year program, Fellows will:Develop knowledge of global regulations and guidelines governing clinical research, such as current Good Clinical Practice (cGCP) and International Council on Harmonization (ICH) guidelinesGain practical experience in the drug development process as an integral part of teams working on actual early phase development clinical studies in various phases from start-up through close-outApply clinical and scientific knowledge to understand the design and conduct of early phase clinical studiesParticipate in didactic seminars, workshops, and group forums related to clinical researchExpand technical writing proficiency of clinical documents such as study protocols and reportsStrengthen presentation skills at internal meetings and at national conferencesEligibilityThe MCPHS Biopharmaceutical Industry fellows will be selected on a nationally competitive basis. Applicants must have a Doctor of Pharmacy degree from an ACPE accredited college of pharmacy at the commencement of the program.Candidates must have strong written and verbal communication skills and a strong interest in pursuing a career within the biopharmaceutical industry.All candidates must have authorization to work in the United States throughout the duration of the one or two year fellowship. No visa sponsorship will be provided (i.e., TN, H-1B, STEM OPT, etc.).Application ProcedureTo be considered for an interview, please complete a fellowship application on the MCPHS SMApply application portal. Visit
https://mcphs.smapply.io/Please
DO NOT
request an interview within PPS. Our recruitment teams will contact qualified candidates via email to schedule interviews.The MCPHS application portal (SMApply) will open up on
Monday, October 7, 2024.
Applicants must upload the following application materials to the
online portal
by
Monday, November 4, 2024 :Letter of intent (addressed to the company specific program director/lead; found in each company brochure)Curriculum vitaeUnofficial college transcriptContact information for three references. References will receive an electronic recommendation form to complete separately.Three recommendation evaluation forms must be submitted no later than
November 20, 2024
via the online portal. This is NOT a letter of recommendation but an online form that the recommender will receive for completion from SMApply.Application Review and Interview TimelineFollowing a review of submitted applications, pre-screens and preliminary interviews will begin in October. Additional interviews, including final rounds will take place in December during ASHP. Candidates will be notified if selected for an interview. The process is rigorous and competitive; therefore candidates should submit their applications well in advance of posted deadlines as priority will be given to those who apply early.ASHP Midyear and Onsite InterviewsThe fellowship program will be conducting
in-person interviews
at the ASHP Midyear Clinical Meeting in New Orleans, LA. Attendance is strongly encouraged, but not required. Candidates attending in-person will not be able to interview without registering for both ASHP and PPS. Please refer to the ASHP & PPS website for registration details.Top candidates may be invited for interviews at the sponsoring company’s location.AIFA First Offer DateThe choice of a Post-Doctoral Fellowship is an important decision. MCPHS, in conjunction with the Alliance of Industry Fellowship Associates (AIFA), has aligned to extend offers for Fellowships no earlier than
December 16, 2024 . We believe this is a positive reflection of the cultures our Programs offer, and that culture is a critical consideration in choice of Fellowship. We hope that other academic and non-academic Fellowship Programs will NOT pressure candidates to accept offers prior to this aligned offer date.We see this respect for candidate choice as a common aspect of each of our Program's cultures. We hope that other academic and non-academic Fellowship Programs will respect this timeline.OnboardingFinal candidates will be required to go through additional screening / onboarding as required by MCPHS.
#J-18808-Ljbffr
The Fellowship is comprised of the Novartis BR industry component and MCPHS academic component. Fellows will spend the majority of their time at Novartis BR obtaining real-world clinical trial experience with a smaller portion of time dedicated to MCPHS activities. Over the course of the two-year program, Fellows will:Develop knowledge of global regulations and guidelines governing clinical research, such as current Good Clinical Practice (cGCP) and International Council on Harmonization (ICH) guidelinesGain practical experience in the drug development process as an integral part of teams working on actual early phase development clinical studies in various phases from start-up through close-outApply clinical and scientific knowledge to understand the design and conduct of early phase clinical studiesParticipate in didactic seminars, workshops, and group forums related to clinical researchExpand technical writing proficiency of clinical documents such as study protocols and reportsStrengthen presentation skills at internal meetings and at national conferencesEligibilityThe MCPHS Biopharmaceutical Industry fellows will be selected on a nationally competitive basis. Applicants must have a Doctor of Pharmacy degree from an ACPE accredited college of pharmacy at the commencement of the program.Candidates must have strong written and verbal communication skills and a strong interest in pursuing a career within the biopharmaceutical industry.All candidates must have authorization to work in the United States throughout the duration of the one or two year fellowship. No visa sponsorship will be provided (i.e., TN, H-1B, STEM OPT, etc.).Application ProcedureTo be considered for an interview, please complete a fellowship application on the MCPHS SMApply application portal. Visit
https://mcphs.smapply.io/Please
DO NOT
request an interview within PPS. Our recruitment teams will contact qualified candidates via email to schedule interviews.The MCPHS application portal (SMApply) will open up on
Monday, October 7, 2024.
Applicants must upload the following application materials to the
online portal
by
Monday, November 4, 2024 :Letter of intent (addressed to the company specific program director/lead; found in each company brochure)Curriculum vitaeUnofficial college transcriptContact information for three references. References will receive an electronic recommendation form to complete separately.Three recommendation evaluation forms must be submitted no later than
November 20, 2024
via the online portal. This is NOT a letter of recommendation but an online form that the recommender will receive for completion from SMApply.Application Review and Interview TimelineFollowing a review of submitted applications, pre-screens and preliminary interviews will begin in October. Additional interviews, including final rounds will take place in December during ASHP. Candidates will be notified if selected for an interview. The process is rigorous and competitive; therefore candidates should submit their applications well in advance of posted deadlines as priority will be given to those who apply early.ASHP Midyear and Onsite InterviewsThe fellowship program will be conducting
in-person interviews
at the ASHP Midyear Clinical Meeting in New Orleans, LA. Attendance is strongly encouraged, but not required. Candidates attending in-person will not be able to interview without registering for both ASHP and PPS. Please refer to the ASHP & PPS website for registration details.Top candidates may be invited for interviews at the sponsoring company’s location.AIFA First Offer DateThe choice of a Post-Doctoral Fellowship is an important decision. MCPHS, in conjunction with the Alliance of Industry Fellowship Associates (AIFA), has aligned to extend offers for Fellowships no earlier than
December 16, 2024 . We believe this is a positive reflection of the cultures our Programs offer, and that culture is a critical consideration in choice of Fellowship. We hope that other academic and non-academic Fellowship Programs will NOT pressure candidates to accept offers prior to this aligned offer date.We see this respect for candidate choice as a common aspect of each of our Program's cultures. We hope that other academic and non-academic Fellowship Programs will respect this timeline.OnboardingFinal candidates will be required to go through additional screening / onboarding as required by MCPHS.
#J-18808-Ljbffr